Sat.Dec 17, 2022 - Fri.Dec 23, 2022

article thumbnail

Artificial Intelligence Applications in Education and Pharmacy Practice

Pharmacy Times

By interpreting and applying the data provided by algorithms, pharmacists are uniquely equipped to guide development of more patient-centered care.

149
149
article thumbnail

Antibiotics For Pediatric Respiratory Tract Infections In The Era Of Amoxicillin Shortages

IDStewardship

In this article a pediatrician puts the 2022-2023 amoxicillin shortage into perspective. . Authored By: Michael Cosimini, M.D. Article Posted 22 December 2022.

246
246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

UK digital health project aims to tackle dysfunctional breathing

Pharma Phorum

A collaboration between academic centres in the UK has won government funding for a digital approach to dysfunctional breathing or dyspnoea, a symptom that affects around 10% of the population.

145
145
article thumbnail

From chemistry to canvas: What the pharma world can learn from art

PharmaVoice

Art and science are often viewed as diametric opposites, but these industry insiders say their passion for painting blends into their pharma work

110
110
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.

article thumbnail

Experts Warn of Spread of Lung Infection-Causing Fungi

Pharmacy Times

Traditionally, endemic fungi are characterized by geographical distribution, however, disease-causing fungi may infect people beyond these havens.

170
170
article thumbnail

How Pfizer Delivered the COVID-19 Vaccine in Record Time

PharmExec

Michael Ku, VP of global clinical supply at Pfizer, shares insights for the c-suite as well as reveals behind-the-scenes insight into Pfizer’s ability to deliver a COVID-19 vaccine swiftly.

More Trending

article thumbnail

With mpox cases mysteriously dwindling, scientists search for answers

PharmaVoice

Was it a public health victory? Or did mpox ‘burn itself out?’ ’ An epidemiologist weighs in

105
105
article thumbnail

Monitoring for Treatment Complications in Patients With Hemophilia A

Pharmacy Times

An array of complications may arise associated with treatment of hemophilia A.

168
168
article thumbnail

2022 in review: Regulation starts to catch up with AI in pharma

Pharmaceutical Technology

Artificial intelligence (AI) continued to stay in the news with several high-profile deals this year, as the pharmaceutical industry readily took to adopting AI models to improve drug discovery.

FDA 140
article thumbnail

FDA approves Adstiladrin as first gene therapy for NMIBC

Pharma Phorum

The US Food and Drug Administration (FDA) has approved Swiss drugmaker Ferring Pharmaceuticals’ Adstiladrin (nadofaragene firedenovec-vncg) for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without papillary tumours.

FDA 119
article thumbnail

Beer, dolphins and more discoveries that could shed light on Alzheimer’s disease

PharmaVoice

New Alzheimer's drugs are poised to change the market — and in preclinical arenas, researchers are learning more and more about the disease

98
article thumbnail

For the First Time, An Anti-Cancer Vaccine May Be Viable, Effectively Reduce Cancer Risk

Pharmacy Times

An anti-cancer vaccine that is now in clinical trials shows promise as a preventative agent. However, experts are unsure when it will be widely available.

Vaccines 153
article thumbnail

Moderna and UK government sign deal to establish mRNA facility

Pharmaceutical Technology

Moderna and the UK government have entered a ten-year strategic collaboration to build a messenger ribonucleic acid (mRNA) research, development and manufacturing facility in the country. The latest development comes after the parties announced an agreement in principle in June this year.

Vaccines 140
article thumbnail

7 commercial, sales, and marketing predictions for 2023

Pharma Phorum

In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). They’ve laid the necessary groundwork for cross-functional visibility, collaboration, and connectivity. And in 2023, these investments will hopefully pay off.

article thumbnail

Blood cancer cures aren’t here yet — but incremental combinations bring the field closer

PharmaVoice

A series of small successes showed promise for the future of blood cancer treatments, particularly in the arena of drug combinations

98
article thumbnail

High Blood Pressure Medication Shows Potential in Preventing Damage from AKI

Pharmacy Times

Investigators hope findings of study in mice help improve treatment for individuals with acute kidney injury.

153
153
article thumbnail

Pfizer, Sanofi settle first California Zantac case slated for trial: report

Fierce Pharma

Pfizer, Sanofi settle first California Zantac case slated for trial: report. zbecker. Thu, 12/22/2022 - 12:38

139
139
article thumbnail

Japanese drugmakers make greener packaging pledge

Pharma Phorum

Four Japanese drugmakers – Astellas, Eisai, Daiichi Sankyo, and Takeda – have joined forces in a partnership intended to reduce the environmental impact of pharmaceutical packaging.

Packaging 105
article thumbnail

From telehealth to Medicare cuts: Here are the health policies in Congress' $1.7T omnibus

Fierce Healthcare

From telehealth to Medicare cuts: Here are the health policies in Congress' $1.7T omnibus. rking. Tue, 12/20/2022 - 10:29

133
133
article thumbnail

Artificial Intelligence Shows Promise in Detection of Anxiety Disorders, Depression

Pharmacy Times

Investigators establish that audio and/or facial video features have been most analyzed by machine learning, followed by electroencephalography signals.

152
152
article thumbnail

Lilly and ProQR to expand genetic medicine development agreement

Pharmaceutical Technology

Eli Lilly and Company has expanded a licencing and partnership agreement with ProQR Therapeutics to discover, develop and market new genetic medicines. The companies entered the initial agreement in September last year.

article thumbnail

Transforming healthcare through sustainable and resilient data infrastructure

Pharma Phorum

In the past two decades, global spending on health has doubled. Yet, optimal healthcare remains out of reach for most of the world as many countries continue to struggle with the burden of disease, growing complexity of healthcare, and persistence of health disparities.

Insurance 105
article thumbnail

2023 forecast: Amid dwindling COVID relief funds, rural hospitals face a 'fiscal cliff'

Fierce Healthcare

2023 forecast: Amid dwindling COVID relief funds, rural hospitals face a 'fiscal cliff'. agliadkovskaya. Mon, 12/19/2022 - 14:42

Hospitals 131
article thumbnail

Study: Travel Times Are Still a Major Obstacle for Women Seeking Breast Cancer Screening

Pharmacy Times

In 10 states, the data showed more than 26% of women had limited accessibility to mammography, primarily in the Rocky Mountains and the South.

151
151
article thumbnail

Atara makes history with world-first nod for allogeneic T-cell therapy Ebvallo

Fierce Pharma

Atara makes history with world-first nod for allogeneic T-cell therapy Ebvallo. fkansteiner. Mon, 12/19/2022 - 14:06

128
128
article thumbnail

Roche claims US approval for lymphoma bispecific Lunsumio

Pharma Phorum

The FDA has given a green light to Roche’s CD20xCD3 bispecific antibody Lunsumio as a treatment for relapsed or refractory follicular lymphoma, following the lead of the European Commission which cleared the drug in June.

article thumbnail

2023 forecast: Providers embrace start of new requirements on health equity

Fierce Healthcare

2023 forecast: Providers embrace start of new requirements on health equity. rking. Mon, 12/19/2022 - 15:28

130
130
article thumbnail

Study: Intermittent Fasting Shows Link to Diabetes Remission

Pharmacy Times

TD2 remission is defined as a hemoglobin A1C level of less than 6.5% at least 1 year after stopping medication, investigators say.

149
149
article thumbnail

Moderna finalises plans for UK mRNA vaccine manufacturing centre

European Pharmaceutical Review

Moderna, Inc. has finalised a strategic partnership with the UK government to establish a state-of-the-art mRNA vaccine research, development, and manufacturing facility in the UK. This milestone follows the agreement in principle between Moderna and the UK Government, announced in June 2022.

Vaccines 124
article thumbnail

Economist Impact: World Cancer Series – pharmaphorum in attendance, day one (part iv)

Pharma Phorum

article thumbnail

Medicare-certified hospitals must supply ownership data

Fierce Healthcare

Medicare-certified hospitals must supply ownership data. fdiamond. Tue, 12/20/2022 - 16:46

Hospitals 128
article thumbnail

Study Results Suggest Exercise, Mindfulness Do Not Boost Cognitive Function in Older Adults

Pharmacy Times

Although physical activity and the practice of being present in the moment are associated with many benefits, analysis shows that neither led to measurable improvements in brain health.

149
149
article thumbnail

EMA CHMP recommends Moderna’s Covid-19 booster for children

Pharmaceutical Technology

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended granting variation to the marketing authorization (MA) for Moderna ’s Spikevax bivalent Original/Omicron BA.1 mRNA-1273.214) booster for usage in children aged six to 11 years.

Vaccines 121
article thumbnail

Life sciences faces a battle with sustainability, but let’s not forget its successes

Pharma Phorum

We know that the global healthcare sector is a contributor to the warming of our planet. It is responsible for 4.4% of annual carbon emissions; if the sector were a country, it would be the world’s fifth biggest global carbon emitter.

98
article thumbnail

'It's finally here': States have long sought Medicaid eligibility redetermination deadline

Fierce Healthcare

It's finally here': States have long sought Medicaid eligibility redetermination deadline. rking. Wed, 12/21/2022 - 16:58

122
122
article thumbnail

Breast Cancer Research, Current Therapeutic Pipeline Provide Significant Advancements in Diagnosis, Treatment

Pharmacy Times

Trends in treatment development involve more targeted, safe, and efficacious therapies.

145
145